THE DEAL, AT A GLANCE
From the announcementAptadir Therapeutics
01What it doesAptadir Therapeutics's headquarters is located at Via San Marco 21A, Milan.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by 4BIO Capital, CE-VenturesFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedAptadir Therapeutics raised Pre-Seed, announced 2026-10-02From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersAptadir Therapeutics is positioned around reactivating genes silenced through aberrant DNA methylation, with the headline citing a €40 Million Seed Round while the round…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Aptadir Therapeutics · Financing Record
Explore source-linked visual explanations for Aptadir Therapeutics. Unsupported claims are withheld while source review continues.
Record 13238 · Recorded date: 2026-10-02
Explore company records →